Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled | King Abdullah Medical City, Makkah | Completed | Dexmedetomidine | 2 | version 4 | KAMC |
| Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled | King Abdullah Medical City, Makkah | Completed | Dexmedetomidine | 2 | version 4 | KAMC |
| International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan | Sanofi | Terminated | Lixisenatide | 3 | LPS14410 | KKUH |
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment | KKUH | Ongoing | N-acetylcysteine | 3 | E-20-4934 | King Khalid University Hospital (Riyadh) |
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment | KKUH | Ongoing | N-acetylcysteine | 3 | E-20-4934 | King Khalid University Hospital (Riyadh) |
| Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. | Celgene | Ongoing | Ozanimod HCl | 3 | RPC01-3201 | KAUH-J |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | SWOG (Southwest Oncology Group) | Ongoing | Ibrutinib | 3 | A051301 | KFSH&RC-R |
| HELIOS-B: A Phase 3, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) | Alnylam Pharmaceuticals. | Ongoing | ALN-TTRSC02 (Vutrisiran) | 3 | ALN-TTRSC02-003 | King Khalid University Hospital (Riyadh) |
| Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma | Roche | Completed | Bevacizumab | 3 | MO22923 | KFMC |
| Freeze dried kale to go, new superfood supplement to reduce metabolic risk in Saudi subjects | The National Plan for Science,Technology and Innovation | Ongoing | Freeze dried kale | 3 | H-01-R-002 | King Khalid University Hospital (Riyadh) |